multiple myeloma

BMS

Pharma

BMS bags first FDA approval for CELMoD franchise with Zenbexus

The approval represents a double landmark, as Zenbexus also marks the first new multiple myeloma drug cleared by the FDA based directly on MRD.

Angus Liu Aug 14, 2026 10:09am

Karyopharm

With cash dwindling and a loan due, Karyopharm faces default

Aug 13, 2026 2:52pm

Legend

Legend interim CEO talks transition, Carvykti challenges

Aug 12, 2026 2:44pm

monumental

J&J bispecific combo delivers 89% PFS benefit in myeloma

Jul 23, 2026 8:30am

Johnson Johnson booth at AACR 2026

EHA: J&J chalks up early-stage myeloma win for Talvey/Darzalex combo

Jun 13, 2026 6:00am

Mariska Hargitay

BMS taps ‘SVU’ detective to investigate myeloma in new campaign

Jun 8, 2026 1:17pm